Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Nasopharyngeal Carcinoma × Taxes × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Nasopharyngeal Carcinoma 1 Breast Neoplasms 1

Interventions

Cisplatin 5 Fluorouracil 4 Capecitabine 4 tislelizumab 2 Radiation 2 Gemcitabine 2 toripalimab 1 temoporfin 1 nimotuzumab 1 fludarabine 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Maintenance Chemotherapy 1 Drug Therapy 1 Cyclophosphamide 1 Cell Count 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Fujian Cancer Hospital

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡